Inovio Pharmaceuticals, Inc. (NYSEMKT:INO) was a big mover last session, as the company saw its shares shoot up nearly 13% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) shares after opening at $3.21 moved to $3.64 on last trade day and at the end of the day closed at $3.64. Company price to sales ratio in past twelve months was calculated as 56.31 and price to cash ratio as 14.45. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) showed a negative weekly performance of -4.21%.
On March 10, 2014, Dynavax Technologies Corporation (NASDAQ:DVAX) issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2013. Dynavax Technologies Corporation (NASDAQ:DVAX) shares advanced 5.95% in last trading session and ended the day on $1.78. DVAX return on equity ratio is recorded as -68.30% and its return on assets is -57.90%. Dynavax Technologies Corporation (NASDAQ:DVAX) yearly performance is -18.35%.
The top executive of Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) is in New York yesterday to present at a cancer conference, the company has announced. Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) shares moved up 15.09% in last trading session and was closed at $7.78, while trading in range of $6.90 – $8.09. Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) year to date (YTD) performance is 106.37%.
Aegis reaffirmed their hold rating on shares of Amarin Co. plc (NASDAQ:AMRN) in a report released on Friday, Stock Ratings Network.com reports. Amarin Corporation plc (ADR) (NASDAQ:AMRN) weekly performance is 4.52%. On last trading day company shares ended up $1.85. Amarin Corporation plc (ADR) (NASDAQ:AMRN) distance from 50-day simple moving average (SMA50) is 1.31%. Analysts mean target price for the company is $2.35.